<DOC>
	<DOCNO>NCT00191867</DOCNO>
	<brief_summary>The purpose study assess Efficacy Safety Teriparatide Japanese Postmenopausal Women Osteoporosis .</brief_summary>
	<brief_title>Clinical Trial Teriparatide Japan</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Teriparatide</mesh_term>
	<criteria>Japanese woman primary osteoporosis Postmenopausal woman age least 55 year Patients high risk fracture History metabolic bone disorder osteoporosis History secondary cause osteoporosis History malignant neoplasm within last 5 year except superficial basal cell carcinoma squamous cell carcinoma skin definitively treat Severe chronically disable condition osteoporosis</criteria>
	<gender>Female</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2007</verification_date>
</DOC>